Correlation Between Enzo Biochem and Exagen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enzo Biochem and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzo Biochem and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzo Biochem and Exagen Inc, you can compare the effects of market volatilities on Enzo Biochem and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzo Biochem with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzo Biochem and Exagen.

Diversification Opportunities for Enzo Biochem and Exagen

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Enzo and Exagen is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Enzo Biochem and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Enzo Biochem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzo Biochem are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Enzo Biochem i.e., Enzo Biochem and Exagen go up and down completely randomly.

Pair Corralation between Enzo Biochem and Exagen

Considering the 90-day investment horizon Enzo Biochem is expected to generate 0.35 times more return on investment than Exagen. However, Enzo Biochem is 2.84 times less risky than Exagen. It trades about 0.05 of its potential returns per unit of risk. Exagen Inc is currently generating about -0.03 per unit of risk. If you would invest  113.00  in Enzo Biochem on July 25, 2024 and sell it today you would earn a total of  3.00  from holding Enzo Biochem or generate 2.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Enzo Biochem  vs.  Exagen Inc

 Performance 
       Timeline  
Enzo Biochem 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Enzo Biochem are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Enzo Biochem is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Exagen Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

Enzo Biochem and Exagen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enzo Biochem and Exagen

The main advantage of trading using opposite Enzo Biochem and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzo Biochem position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.
The idea behind Enzo Biochem and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamental Analysis
View fundamental data based on most recent published financial statements
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA